Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trials.

Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trials.

Inflammation is a common feature in patients with type 2 diabetes mellitus (T2DM). This meta-analysis aimed to assess the influence of thiazolidinedione (TZD) therapy on the circulating levels of inflammatory markers in patients with T2DM.We searched the databases Medline, Embase, ScienceDirect, Web...

Full description

Bibliographic Details
Main Authors:	Rui Chen, Jinchuan Yan, Peijing Liu, Zhongqun Wang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4405205?pdf=render

Similar Items

Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
by: Yueli Zhu, et al.
Published: (2019-01-01)

Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
by: Yenny Yenny
Published: (2016-04-01)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
by: Anthony H Barnett
Published: (2009-01-01)

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
by: Zhiwei Zhang, et al.
Published: (2017-04-01)

Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
by: Yang Liu, et al.
Published: (2018-01-01)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
by: John M Stafford, et al.
Published: (2007-09-01)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
by: John M Stafford, et al.
Published: (2007-10-01)

Use of thiazolidinediones and risk of hospitalization for myocardial infarction with type 2 diabetes
by: Shu-Ting Chan, et al.
Published: (2009)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
by: Jaehyun Bae, et al.
Published: (2021-05-01)

Factors associated with results and conclusions of trials of thiazolidinediones.
by: Gail Rattinger, et al.
Published: (2009-06-01)

Physical Exercise on Inflammatory Markers in Type 2 Diabetes Patients: A Systematic Review of Randomized Controlled Trials
by: Luciana Costa Melo, et al.
Published: (2017-01-01)

Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis
by: Wen Wang, et al.
Published: (2017-05-01)

Effects of Exercise on Inflammatory Cytokines in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
by: Xiaoke Chen, et al.
Published: (2020-01-01)

Risk of fracture with thiazolidinediones: an individual patient data meta-analysis
by: Marloes T Bazelier, et al.
Published: (2013-02-01)

Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: A randomized, placebo-controlled trial
by: Golbon Sohrab, et al.
Published: (2014-01-01)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
by: Mazzone Peter J, et al.
Published: (2012-09-01)

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
by: D. Alemán-González-Duhart, et al.
Published: (2016-01-01)

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
by: Behzad Molavi, et al.
Published: (2008-01-01)

To evaluate the effects of thiazolidinediones on blood lipid levels in patients with type 2 diabetes mellitus.
by: Tai-Cheng Yu, et al.
Published: (2008)

The evaluation of dyslipidemia benefit effect of Thiazolidinediones with Statins in patients with type 2 diabetes mellitus
by: Hou-Jen Huang, et al.
Published: (2008)

Study of Inappropriate Thiazolidinediones Prescribing among Patient with Type Two Diabetes and Heart Failure
by: Yin-Yun Huang, et al.
Published: (2009)

Chemotherapy and Chemoprevention by Thiazolidinediones
by: Eleonore Fröhlich, et al.
Published: (2015-01-01)

The effects of glycemic control and thiazolidinediones on the risk of congestive heart failure among patients with type 2 diabetes
by: Filion, Kristian
Published: (2009)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01)

Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Linda Zhong, et al.
Published: (2019-07-01)

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
by: Glaucia S. Tres, et al.
Published: (2018-01-01)

Evaluation of the clinical manifestation and side effects of type 2 diabetics used insulin treated with thiazolidinedione
by: Tzu-Tsen Kuo, et al.
Published: (2011)

Effects of Thiazolidinediones in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation
by: Hsien-Tsung Yeh, et al.
Published: (2010)

Utilisation des thiazolidinediones chez les patients atteints de diabète de type 2
by: Leblond, Julie
Published: (2003)

DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
by: Esther W Y Chan, et al.
Published: (2020-04-01)

The Effects of N-acetylcysteine on Inflammatory Markers and Homocysteine: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Jamal Hallajzadeh, et al.
Published: (2020-09-01)

Effect of Vitamin D Supplementation on Inflammatory Markers in Non-Obese Lebanese Patients with Type 2 Diabetes: A Randomized Controlled Trial
by: Cynthia El Hajj, et al.
Published: (2020-07-01)

Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials
by: White, C. Michael, et al.
Published: (2020)

Appropriateness of the use of Thiazolidinediones for the treatment of Type 2 Diabetes Mellitus at the Southern Arizona Veterans Affairs Hospital
by: Fletcher, Glory, et al.
Published: (2005)

The effect and estimate by using thiazolidinediones、 Metformin、Sulfonylureas and Insulin for diabetes’s complication
by: Te-Lung Chien, et al.
Published: (2005)

Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials
by: Xin Wei, et al.
Published: (2012-09-01)

Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of Thiazolidinediones for diabetes
by: Tsai Chia-Rung, et al.
Published: (2011-01-01)

The Effects of Bariatric Procedures versus Medical Therapy for Obese Patients with Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials
by: Xiaohu Guo, et al.
Published: (2013-01-01)

Effect of Aerobic Exercise on Inflammatory Markers in Healthy Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Guohua Zheng, et al.
Published: (2019-04-01)

Pharmacoepidemiology Study of Thiazolidinediones on Type II Diabetes Mellitus Patients – Risk Analysis of Cardiovascular Related Adverse Effects
by: Yi-shiu Lin, et al.
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uon0bqb98bt7jsrlkohhvqm4ta